|
RAB3D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.19770000028829E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.03679999999973E-05 |
| Normal-vs-Stage2 |
1.380580E-03 |
| Normal-vs-Stage3 |
1.201920E-03 |
| Normal-vs-Stage4 |
6.606000E-02 |
| Stage1-vs-Stage2 |
7.533400E-01 |
| Stage1-vs-Stage3 |
1.075220E-01 |
| Stage1-vs-Stage4 |
2.824400E-01 |
| Stage2-vs-Stage3 |
2.215800E-01 |
| Stage2-vs-Stage4 |
3.490800E-01 |
| Stage3-vs-Stage4 |
7.360200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16419999995898E-06 |
| Normal-vs-AfricanAmerican |
1.637330E-04 |
| Normal-vs-Asian |
2.242600E-01 |
| Caucasian-vs-AfricanAmerican |
9.914800E-01 |
| Caucasian-vs-Asian |
8.184200E-01 |
| AfricanAmerican-vs-Asian |
8.054200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.423500E-04 |
| Normal-vs-Female |
2.42429998298377E-09 |
| Male-vs-Female |
3.60230000000517E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.078460E-03 |
| Normal-vs-Extreme_Weight |
1.243370E-03 |
| Normal-vs-Obese |
1.52266999999817E-05 |
| Normal-vs-Extreme_Obese |
3.452400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.816560E-01 |
| Normal_Weight-vs-Obese |
6.018000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.242500E-02 |
| Extreme_Weight-vs-Obese |
2.586100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.383800E-01 |
| Obese-vs-Extreme_Obese |
7.921300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.638310E-03 |
| Normal-vs-Age(41-60Yrs) |
1.08539999987833E-07 |
| Normal-vs-Age(61-80Yrs) |
3.247700E-04 |
| Normal-vs-Age(81-100Yrs) |
7.725600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.192020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.737500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.502220E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.476080E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.967830E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.256800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.92380000047154E-07 |
| Normal-VS-Type2 PRCC |
2.701900E-02 |
| Normal-VS-KIRP CIMP |
9.53510000000213E-05 |
| Normal-VS-Unclassified PRCC |
1.381250E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.586200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.37719835535677E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
8.362000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.445300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.232570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.26659999447554E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.010460E-02 |
| Normal-vs-N1 |
8.628000E-04 |
| Normal-vs-N2 |
1.298810E-01 |
| N0-vs-N1 |
2.234300E-02 |
| N0-vs-N2 |
1.880010E-01 |
| N1-vs-N2 |
2.274800E-01 |
|
|
